CXL treats radial keratotomy in the short-term

Article

Patients with radial keratotomy (RK) can be successfully treated with corneal cross-linking (CXL).

According to new results published in the journal Cornea patients with radial keratotomy (RK) can be successfully treated with corneal cross-linking (CXL).

The short-term case series, conducted by Dr Graciana Fuentes-Páez et al., Clinica Tacir-Centro Medico Teknon, Barcelona, Spain, featured seven eyes of four RK patients who underwent CXL with riboflavin and UV-A radiation.

Sphere, spherical equivalent (SE), uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), topographic astigmatism, mean topographic K (Km), pachymetry and Q values were all recorded 3 and 6 months after CXL.

After three months the findings revealed that the mean sphere of the patients was +1.0 ± 3.0 D, the astigmatism was 2.5 ± 1.2 D, SE was 0.3 ± 2.2 D and UCVA 0.41 ± 2.7. Additional findings showed that mean BSCVA was 0.80 ± 0.27, Km was 37.5 ± 5.7 D, pachymetry was 491 ± 33.74 μm and Q values were 2.27 ± 1.8.

Six months after CXL the findings improved further. Mean sphere was 0.53 ± 3.5 D, astigmatism was 1.62 ± 1.76 D, SE was 0.52 ± 2.9 D, UCVA was0.60 ± 2.0, BSCVA was 0.9 ± 0.15, Km was 38.3 ± 4.10 D, and Q values were 1.7 ± 0.78.

The data demonstrated a statistical and clinical significance in all areas on RK patients who underwent CXL.

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Related Content
© 2023 MJH Life Sciences

All rights reserved.